APA (7th ed.) Citation

T, S., K, B., A, C., BL, W., LE, B., D, G., . . . H, L. (2025). Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: A retrospective multicenter analysis. Experimental hematology & oncology, 14(1), 36. https://doi.org/10.1186/s40164-025-00629-4

Chicago Style (17th ed.) Citation

T, Schieber, et al. "Efficacy and Safety of Immune Checkpoint Inhibitors in Metastatic Penile Squamous Cell Carcinoma: A Retrospective Multicenter Analysis." Experimental Hematology & Oncology 14, no. 1 (2025): 36. https://doi.org/10.1186/s40164-025-00629-4.

MLA (9th ed.) Citation

T, Schieber, et al. "Efficacy and Safety of Immune Checkpoint Inhibitors in Metastatic Penile Squamous Cell Carcinoma: A Retrospective Multicenter Analysis." Experimental Hematology & Oncology, vol. 14, no. 1, 2025, p. 36, https://doi.org/10.1186/s40164-025-00629-4.